XML 20 R6.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Operating activities:    
Cash provided by operating activities $ 23,711 $ 15,876
Investing activities:    
Capital expenditures (18,293) (19,683)
Proceeds from sale of royalty interests in oil properties 2,949  
Proceeds from sale of equipment 129 29
Proceeds from maturities of certificates of deposit 245 760
Proceeds from sale of business   8,000
Cash used in investing activities (14,970) (10,894)
Financing activities:    
Payments of bank debt (27,363) (21,767)
Bank borrowings 12,000 14,000
Deferred financing costs   (608)
Proceeds from noncontrolling interests (Note 13)   4,000
Taxes paid on vesting of RSUs (7) (11)
Dividends (2,483) (2,471)
Cash used in financing activities (17,853) (6,857)
Increase in cash ,cash equivalents, and restricted cash (9,112) (1,875)
Cash, cash equivalents, and restricted cash beginning of year 20,094 16,294
Cash, cash equivalents, and restricted cash end of year 10,982 14,419
Cash, cash equivalents, and restricted cash consists of the following:    
Cash, cash equivalents, and restricted cash, Total 20,094 16,294
Supplemental cash flow information:    
Capital expenditures included in accounts payable, net 5,544 $ (6,474)
Right-to-use asset due to adoption of ASU 2016-02 $ 942